🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This study aims to evaluate the persistence of anti-poliovirus antibodies i...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-25
Trial ID
NCT01323647
Treatments Being Tested
This study will be conducted in two stages. In the diphtheria, tetanus, per...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06-16
Trial ID
NCT00228917
Treatments Being Tested
This study evaluates the immunogenicity and safety of Infanrix hexa™ (DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781